Oral Mucositis clinical trials

Explore recruiting oral mucositis clinical trials.

Recruiting oral mucositis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oral Mucositis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Comparison of esketamine mouthwash versus intravenous administration for the treatment of chemotherapy/radiotherapy-induced mucositis

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

MucPreDex: Radiation-induced MUCositis PREvention using DEXpanthenol mouth rinse

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, open-label, Phase III trial to assess the efficacy and safety of BupiZenge compared to lidocaine for pain associated with oral mucositis in head and neck cancer

Germany, Denmark, Norway, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase II, Randomized, Open-Label Study Evaluating Two Inavolisib Dose Levels in Combination with Fulvestrant in Participants with PIK3CA-Mutated, HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

Belgium, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Patient reported outcomes in term of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced head and neck cancer patients treated with definitive chemo-radiotherapy

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-label, Multinational Study Assessing the Efficacy and Safety of Dato-DXd Treatment in Patients With HR-positive, HER2 IHC 0, Locally Advanced Inoperable or Metastatic Breast Cancer Refractory to Endocrine Therapy (TROPION-Breast06)

Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Oral Mucositis trials by city

Oral Mucositis in Toronto Oral Mucositis in Vancouver Oral Mucositis in Montreal Oral Mucositis in Calgary Oral Mucositis in Edmonton Oral Mucositis in Ottawa Oral Mucositis in Winnipeg Oral Mucositis in Quebec City Oral Mucositis in Hamilton Oral Mucositis in Kitchener Oral Mucositis in London Oral Mucositis in Halifax Oral Mucositis in New York Oral Mucositis in Los Angeles Oral Mucositis in Chicago Oral Mucositis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease